$JSDA
JONES SODA CO Stock $jsda

$jsda Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000143774924017021 Filed on May 15, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$7.157M	$4.999M
YoY Change	48.92%	29.17%
Cost Of Revenue	$4.596M	$3.107M
YoY Change	41.55%	13.6%
Gross Profit	$2.561M	$1.892M
YoY Change	64.27%	66.7%
Gross Profit Margin	35.78%	37.85%
Selling, General & Admin	$4.152M	$3.037M
YoY Change	60.43%	22.07%
% of Gross Profit	162.12%	160.52%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$12.00K	$15.00K
YoY Change	-40.0%	66.67%
% of Gross Profit	0.47%	0.79%
Operating Expenses	$4.152M	$3.037M
YoY Change	60.43%	22.07%
Operating Profit	-$1.591M	-$1.145M
YoY Change	54.62%	-15.37%
Interest Expense	$7.000K	$9.000K
YoY Change
% of Operating Profit
Other Income/Expense, Net	$39.00K	-$6.000K
YoY Change	875.0%	20.0%
Pretax Income	-$1.557M	-$1.142M
YoY Change	54.62%	-15.91%
Income Tax	$11.00K	$10.00K
% Of Pretax Income
Net Earnings	-$1.568M	-$1.200M
YoY Change	53.13%	-11.96%
Net Earnings / Revenue	-21.91%	-24.0%
Basic Earnings Per Share	-$0.02	-$0.01
Diluted Earnings Per Share	-$0.02	-$0.01
COMMON SHARES
Basic Shares Outstanding	102.2M	102.2M
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.456M	$2.827M
YoY Change	-71.32%	-56.04%
Cash & Equivalents	$1.500M	$2.800M
Short-Term Investments
Other Short-Term Assets	$1.675M	$1.241M
YoY Change	20.5%	23.85%
Inventory	$4.357M	$3.589M
Prepaid Expenses
Receivables	$4.730M	$3.258M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$12.22M	$10.92M
YoY Change	-2.54%	-21.94%
LONG-TERM ASSETS
Property, Plant & Equipment	$110.0K	$121.0K
YoY Change	-9.09%	-3.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$111.0K	$151.0K
YoY Change
Total Long-Term Assets	$221.0K	$272.0K
YoY Change	82.64%	117.6%
TOTAL ASSETS
Total Short-Term Assets	$12.22M	$10.92M
Total Long-Term Assets	$221.0K	$272.0K
Total Assets	$12.44M	$11.19M
YoY Change	-1.72%	-20.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.198M	$2.387M
YoY Change	304.04%	27.65%
Accrued Expenses	$2.401M	$2.007M
YoY Change	54.31%	66.14%
Deferred Revenue
YoY Change
Short-Term Debt	$254.0K	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.976M	$4.632M
YoY Change	149.05%	32.46%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.976M	$4.632M
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$6.976M	$4.632M
YoY Change	149.05%	32.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$85.80M	-$84.20M
YoY Change	6.47%	5.83%
Common Stock	$90.97M	$90.48M
YoY Change	0.96%	0.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.463M	$6.555M
YoY Change
Total Liabilities & Shareholders Equity	$12.44M	$11.19M
YoY Change	-1.72%	-20.7%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$1.568M	-$1.200M
YoY Change	53.13%	-11.96%
Depreciation, Depletion And Amortization	$12.00K	$15.00K
YoY Change	-40.0%	66.67%
Cash From Operating Activities	-$1.497M	-$958.0K
YoY Change	29.27%	-26.31%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	$0.00
YoY Change	-100.0%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	172.0K	-$75.00K
YoY Change	-184.31%	-63.24%
NET CHANGE
Cash From Operating Activities	-1.497M	-$958.0K
Cash From Investing Activities	0.000	$0.00
Cash From Financing Activities	172.0K	-$75.00K
Net Change In Cash	-1.325M	-$1.033M
YoY Change	-3.99%	-32.88%
FREE CASH FLOW
Cash From Operating Activities	-$1.497M	-$958.0K
Capital Expenditures	$0.00	$0.00
Free Cash Flow	-$1.497M	-$958.0K
YoY Change	27.3%	-26.7%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	252000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	260000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	381000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	366000	usd
CY2024Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	102232943
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	102232943
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	101258135
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	101258135
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	108542
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	000-28820
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	WA
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	52-2336602
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	4786 1st Avenue South, Suite 103
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Seattle
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	WA
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	98134
CY2024Q1	dei	City Area Code CityAreaCode	206
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	624-3357
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	102232943
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2827000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3867000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3258000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2118000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	3589000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2392000	usd
CY2024Q1	jsda	Prepaid Insurance Current PrepaidInsuranceCurrent	238000	usd
CY2023Q4	jsda	Prepaid Insurance Current PrepaidInsuranceCurrent	357000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1003000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	861000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	10915000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	9595000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	151000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	174000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	121000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	137000	usd
CY2024Q1	us-gaap	Assets Assets	11187000	usd
CY2023Q4	us-gaap	Assets Assets	9906000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2387000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	716000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2007000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1283000	usd
CY2024Q1	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	238000	usd
CY2023Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	357000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	4632000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2356000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	4632000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2356000	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	90475000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	90273000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	286000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	331000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-84206000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-83054000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	6555000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	7550000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11187000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9906000	usd
CY2024Q1	us-gaap	Revenues Revenues	4999000	usd
CY2023Q1	us-gaap	Revenues Revenues	3870000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3107000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2735000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	1892000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	1135000	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1492000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1032000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1545000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1456000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	3037000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2488000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1145000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1353000	usd
CY2024Q1	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	9000	usd
CY2023Q1	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	0	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1142000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1358000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1152000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1363000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101477735
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	100451635
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1152000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1363000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-45000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	3000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1197000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1360000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11767000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	266000	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	62000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1363000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	10611000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	7550000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	158000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	44000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1152000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-45000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	6555000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1152000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1363000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	15000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	158000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	266000	usd
CY2024Q1	jsda	Accounts Receivable Credit Loss Expense Reversal Less Writeoffs AccountsReceivableCreditLossExpenseReversalLessWriteoffs	-8000	usd
CY2023Q1	jsda	Accounts Receivable Credit Loss Expense Reversal Less Writeoffs AccountsReceivableCreditLossExpenseReversalLessWriteoffs	5000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1153000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	96000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1206000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	664000	usd
CY2024Q1	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	119000	usd
CY2023Q1	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	204000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	141000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-7000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-24000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-0	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1671000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	800000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	715000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-497000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-958000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1328000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-0	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	44000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	usd
CY2024Q1	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	119000	usd
CY2023Q1	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	204000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-75000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-204000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1033000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1539000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-7000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-1000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3867000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7971000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2827000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6431000	usd
CY2024Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	7000	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	4000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	5862975
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2800000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3900000	usd
CY2024Q1	jsda	Working Capital Deficit WorkingCapitalDeficit	6300000	usd
CY2023Q4	jsda	Working Capital Deficit WorkingCapitalDeficit	7200000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-958000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1300000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1200000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1400000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-84200000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-79600000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-75000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-204000	usd
CY2024Q1	jsda	Slotting Fees And Promotional Allowances SlottingFeesAndPromotionalAllowances	442000	usd
CY2023Q1	jsda	Slotting Fees And Promotional Allowances SlottingFeesAndPromotionalAllowances	305000	usd
CY2024Q1	jsda	Maximum Discount For Customers Payment Made Within15 Days MaximumDiscountForCustomersPaymentMadeWithin15Days	0.02	pure
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	252000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	260000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	0.33
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6767280
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.33
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3447666
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.34
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2224000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1380000	usd
CY2024Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1365000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1012000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	3589000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2392000	usd
CY2024Q1	us-gaap	Inventory Write Down InventoryWriteDown	38000	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	6000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11407772
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.26
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2200000
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.24
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	41250
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.41
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13566522
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.25
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4459388
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.3
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	11519254
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	0.26
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3369322
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.41
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3506500
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.26
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.3
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1000000	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y1M6D
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	158000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	266000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	158000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	266000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	95000	usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	39000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6022102
CY2024Q1	jsda	Class Of Warrant Or Right Exercisable ClassOfWarrantOrRightExercisable	6022102
CY2024Q1	us-gaap	Revenues Revenues	4999000	usd
CY2023Q1	us-gaap	Revenues Revenues	3870000	usd

Files In Submission

Name	View Source	Status
0001437749-24-017021-index-headers.html	Edgar Link	pending
0001437749-24-017021-index.html	Edgar Link	pending
0001437749-24-017021.txt	Edgar Link	pending
0001437749-24-017021-xbrl.zip	Edgar Link	pending
ex_662435.htm	Edgar Link	pending
ex_662436.htm	Edgar Link	pending
ex_662437.htm	Edgar Link	pending
ex_662438.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
jsda-20240331.xsd	Edgar Link	pending
jsda20240331_10q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
jsda-20240331_cal.xml	Edgar Link	unprocessable
jsda-20240331_def.xml	Edgar Link	unprocessable
jsda-20240331_lab.xml	Edgar Link	unprocessable
jsda-20240331_pre.xml	Edgar Link	unprocessable
jsda20240331_10q_htm.xml	Edgar Link	completed
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JSDA
JONES SODA CO Stock $jsda

2024 Q2 Form 10-Q Financial Statement

#000143774924017021 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JSDA JONES SODA CO Stock $jsda

2024 Q2 Form 10-Q Financial Statement

#000143774924017021 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JSDA
JONES SODA CO Stock $jsda